Nutex Health COO granted 2,411 RSUs

Nutex Health Inc. reported that Chief Operating Officer Wesley Shane Bamburg acquired 2,411 restricted stock units (RSUs) on March 11, 2026 as equity compensation.

Rhea-AI Filing Summary

Nutex Health Inc. reported that Chief Operating Officer Wesley Shane Bamburg acquired 2,411 restricted stock units (RSUs) on March 11, 2026 as equity compensation. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, aligning Bamburg’s incentives with the company’s long-term performance rather than reflecting any open-market share purchase or sale.

Insider Trade Summary

2,411 shares exercised/converted

Exercise 1 txn

Insider Bamburg Wesley Shane

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	2,411	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 2,411 contracts (Direct)

Footnotes (2)

1. F1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
2. F2. On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NUTX report for Wesley Shane Bamburg?

Nutex Health reported an equity grant to Chief Operating Officer Wesley Shane Bamburg of 2,411 restricted stock units on March 11, 2026. These RSUs are compensation-related awards, not open-market trades, and convert into common shares only as they vest over time.

How many RSUs did the Nutex Health (NUTX) COO receive and when do they vest?

The COO received 2,411 RSUs, granted on March 11, 2026. They vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, gradually delivering common shares as long-term service and performance conditions are satisfied.

Does the NUTX Form 4 show an open-market stock purchase or sale?

No, the Form 4 shows an RSU grant, classified as a derivative exercise/conversion, not an open-market buy or sell. The award gives rights to future common shares upon vesting, reflecting routine executive compensation rather than immediate trading activity in Nutex Health’s stock.

What does each Nutex Health (NUTX) RSU granted to the COO represent?

Each RSU represents one future common share of Nutex Health’s stock, with a par value of $0.001, deliverable when the unit vests. This structure ties the executive’s compensation to the company’s equity value over the multi-year vesting schedule disclosed.

How many Nutex Health (NUTX) shares will the COO hold from this award after vesting?

If all RSUs vest, the award can deliver 2,411 shares of common stock, because each restricted stock unit converts into one share upon vesting. Actual shares received depend on continued vesting through 2027, 2028, and 2029 as described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 03:41 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bamburg Wesley Shane

(Last) (First) (Middle)

1776 YORKTOWN STREET

C/O NUTEX HEALTH INC.

(Street)

HOUSTON TEXAS 77056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/11/2026		M		2,411(1)		03/01/2027(2)	03/01/2029(2)	Common Stock	2,411	$0	2,411	D

Explanation of Responses:

1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

2. On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Wesley Shane Bamburg	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)